Interstitial Pneumonitis and Alveolar Hemorrhage Complicating Use of Rituximab

被引：33

作者：

Heresi, Gustavo A. ^{[1
]}

Farver, Carol F. ^{[2
]}

Stoller, James K. ^{[1
]}

机构：

[1] Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Cleveland, OH 44106 USA

[2] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA

来源：

RESPIRATION | 2008年 / 76卷 / 04期

关键词：

Drug-induced lung toxicity; Pneumonitis; Diffuse alveolar hemorrhage; Rituximab;

D O I：

10.1159/000104866

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The use of rituximab has been uncommonly associated with delayed pulmonary toxicity. We present a case of interstitial pneumonitis and diffuse alveolar hemorrhage, which represents the second such case reported in the literature. Copyright (c) 2007 S. Karger AG, Basel

引用

页码：449 / 453

页数：5

共 19 条

[1] Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma [J].

Alexandrescu, DT ;

Dutcher, JP ;

O'Boyle, K ;

Albulak, M ;

Oiseth, S ;

Wiernik, PH .

LEUKEMIA & LYMPHOMA, 2004, 45 (11) :2321-2325

[2]

[Anonymous], RITUXAN

[3] Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma [J].

Biehn, Suzanne E. ;

Kirk, David ;

Rivera, M. Patricia ;

Martinez, Antonio E. ;

Khandani, Amir H. ;

Orlowski, Robert Z. .

HEMATOLOGICAL ONCOLOGY, 2006, 24 (04) :234-237

[4]

Burton C, 2003, NEW ENGL J MED, V348, P2690

[5] Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712) [J].

Byrd, JC ;

Peterson, BL ;

Morrison, VA ;

Park, K ;

Jacobson, R ;

Hoke, E ;

Vardiman, JW ;

Rai, K ;

Schiffer, CA ;

Larson, RA .

BLOOD, 2003, 101 (01) :6-14

[6] Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma:: Results of a phase II trial of rituximab [J].

Davis, TA ;

White, CA ;

Grillo-López, AJ ;

Velásquez, WS ;

Link, B ;

Maloney, DG ;

Dillman, RO ;

Williams, ME ;

Mohrbacher, A ;

Weaver, R ;

Dowden, S ;

Levy, R .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1851-1857

[7] First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: Phase II trial [J].

Hainsworth, JD ;

Litchy, S ;

Lamb, MR ;

Rodriguez, GI ;

Scroggin, C ;

Greco, FA .

CLINICAL LYMPHOMA, 2003, 4 (01) :36-42

[8] Cyclophosphamide-induced late-onset lung disease [J].

Hamada, K ;

Nagai, S ;

Kitaichi, M ;

Jin, G ;

Shigematsu, M ;

Nagao, T ;

Sato, A ;

Mishima, M .

INTERNAL MEDICINE, 2003, 42 (01) :82-87

[9] Fludarabine-related pulmonary toxicity - A distinct clinical entity in chronic lymphoproliferative syndromes [J].

Helman, DL ;

Byrd, JC ;

Ales, NC ;

Shorr, AF .

CHEST, 2002, 122 (03) :785-790

[10] Fatal interstitial pneumonitis related to rituximab-containing regimen [J].

Herishanu, Y ;

Polliack, A ;

Leider-Trejo, L ;

Grieff, Y ;

Metser, U ;

Naparstek, E .

CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (05) :407-409

← 1 2 →